You are here

Update on Primary Therapy, Second-Line Therapy, and New Agents for Chronic Myelogenous Leukemia

NCCN 2nd Annual Congress: Hematologic Malignancies - Update on Primary Therapy, Second-Line Therapy, and New Agents for Chronic Myelogenous Leukemia (Slides with Audio) CME/CE Jerald P. Radich, MD

Radich, MD

...here